alternatives to glp 1 drugs GLP-1 for Employers How GLP-1 medications are transforming

UP NEXT The growing struggle of finding caregivers for seniors as the population in the U.S

Even so, they're already outlining their visions for the future of obesity drugs

Drug: GZR18 GZR18, developed by Gan and Lee Pharmaceuticals, USA, is currently undergoing a Phase II trial to assess its efficacy and safety for weight management in obese or overweight individuals

Clinical studies have shown that patients can expect significant weight loss (around 5-10% of their body weight) after about 6 months of consistent use, although individual results may vary based on lifestyle factors such as diet and exercise

For instance, if Lillys new plant had scaled tirzepatide 10% off-target without detection, product release would fail

And that's harder than it sounds when nothing sounds appetizing